These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4624148)

  • 1. "Unmasking" of human lymphoid cell heteroantigens by neuraminidase treatment.
    Rosenberg SA; Plocinik BA; Rogentine GN
    J Natl Cancer Inst; 1972 May; 48(5):1271-6. PubMed ID: 4624148
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation of the neuraminidase-revealed antigens of human lymphocytes and erythrocytes.
    Reisner EG
    Transplantation; 1975 Apr; 19(4):357-60. PubMed ID: 1171544
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential release of sialic acid from normal and malignant cells by Vibrio cholerae neuraminidase or influenza virus neuraminidase.
    Ray RK; Simmons RL
    Cancer Res; 1973 May; 33(5):936-9. PubMed ID: 4703124
    [No Abstract]   [Full Text] [Related]  

  • 4. The serologic behaviour of neuraminidase-treated lymphoid cells. Alloantigenicity and complement sensitivity.
    Ray PK; Gewurz H; Simmons RL
    Clin Exp Immunol; 1972 Jul; 11(3):441-60. PubMed ID: 5042921
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity of leukemia L1210 cells after neuraminidase treatment.
    Bekesi JG; St Arneault G; Walter L; Holland JF
    J Natl Cancer Inst; 1972 Jul; 49(1):107-18. PubMed ID: 4338766
    [No Abstract]   [Full Text] [Related]  

  • 6. The direct determination of cytolytic antibody titer and specificity.
    Stewart CC; Goldstein S
    J Lab Clin Med; 1974 Sep; 84(3):425-37. PubMed ID: 4408372
    [No Abstract]   [Full Text] [Related]  

  • 7. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
    [No Abstract]   [Full Text] [Related]  

  • 8. The cytotoxic reactivity and sialic acid content of human lymphoid cells.
    Reisner EG; Flye MW; Chung KS; Amos DB
    Tissue Antigens; 1974; 4(1):7-20. PubMed ID: 4545917
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuraminidase and anti-neuraminidase serum: effect on the cell surface properties.
    Sachtleben P; Gsell R; Mehrishi JN
    Vox Sang; 1973 Dec; 25(6):519-28. PubMed ID: 4205110
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific effect of neuraminidase on blastogenic response of sensitized lymphocytes.
    Han T
    Immunology; 1975 Feb; 28(2):283-6. PubMed ID: 1168168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis- and trans-membrane control of cell surface topography.
    Nicolson GL
    J Supramol Struct; 1973; 1(4):410-6. PubMed ID: 4767466
    [No Abstract]   [Full Text] [Related]  

  • 13. Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment.
    Bekesi JG; St-Arneault G; Holland JF
    Cancer Res; 1971 Dec; 31(12):2130-2. PubMed ID: 5120303
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 15. Sialic acid masked membrane antigens of clonal functional glial cells.
    Herschman HR; Breeding J; Nedrud J
    J Cell Physiol; 1972 Apr; 79(2):249-58. PubMed ID: 5063616
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro evidence that Vibrio Cholerae neuraminidase increases antigenicity of sarcoma cells.
    Faraci RP; Ketcham AS
    Surg Forum; 1974; 25(0):99-101. PubMed ID: 4439267
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral antibody response and GVH reactivity with neuraminidase treated murine lymphocytes as donor cells.
    Adolphs HD
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 146(1):45-54. PubMed ID: 4157051
    [No Abstract]   [Full Text] [Related]  

  • 18. Are N-glycolylneuraminic acid (Hanganutziu-Deicher) antigens important in pig-to-human xenotransplantation?
    Miwa Y; Kobayashi T; Nagasaka T; Liu D; Yu M; Yokoyama I; Suzuki A; Nakao A
    Xenotransplantation; 2004 May; 11(3):247-53. PubMed ID: 15099204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuraminidase treatment on CFUs properties and CFUs numbers.
    Bol S; van Slingerland V; van Vliet M
    Exp Hematol; 1982 Apr; 10(4):393-403. PubMed ID: 6807703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total cell-associated immunoglobulin (TCAI) and immunoglobulin (Ig)synthesis of human leukocytes.
    Longmire R; McMillan R; Yelenosky R; Craddock C
    Trans Assoc Am Physicians; 1971; 84():229-38. PubMed ID: 5172851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.